YiChang HEC ChangJiang Pharmaceutical 過去の業績
過去 基準チェック /36
YiChang HEC ChangJiang Pharmaceuticalの収益は年間平均-2.1%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間5.7% 6%割合で 増加しています。 YiChang HEC ChangJiang Pharmaceuticalの自己資本利益率は17.5%であり、純利益率は29.7%です。
主要情報
-2.1%
収益成長率
-1.7%
EPS成長率
Pharmaceuticals 業界の成長 | 5.6% |
収益成長率 | 6.0% |
株主資本利益率 | 17.5% |
ネット・マージン | 29.7% |
前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues
Oct 07Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?
Sep 19YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%
May 29Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?
Apr 23YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce
Mar 01Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%
Mar 01YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't
Jan 03YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt
Sep 25Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?
Nov 25Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?
Mar 23Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?
Oct 29Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden
Apr 13YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially
Mar 23YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.
Mar 13YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?
Feb 20Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?
Feb 02YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 26Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend
Dec 13What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Nov 30収支内訳
収支内訳
YiChang HEC ChangJiang Pharmaceutical の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
30 Jun 24 | 5,540 | 1,648 | 1,891 | 360 |
31 Mar 24 | 5,917 | 1,820 | 1,915 | 276 |
31 Dec 23 | 6,295 | 1,993 | 1,939 | 192 |
30 Sep 23 | 5,978 | 1,566 | 1,870 | 190 |
30 Jun 23 | 5,661 | 1,139 | 1,801 | 187 |
31 Mar 23 | 4,703 | 608 | 1,676 | 158 |
31 Dec 22 | 3,745 | 77 | 1,551 | 130 |
30 Sep 22 | 2,875 | -18 | 1,324 | 115 |
30 Jun 22 | 2,005 | -113 | 1,097 | 101 |
31 Mar 22 | 1,459 | -351 | 990 | 105 |
31 Dec 21 | 914 | -588 | 883 | 110 |
30 Sep 21 | 690 | -436 | 986 | 98 |
30 Jun 21 | 467 | -285 | 1,089 | 87 |
31 Mar 21 | 1,407 | 277 | 1,278 | 90 |
31 Dec 20 | 2,348 | 839 | 1,468 | 92 |
30 Sep 20 | 3,792 | 1,204 | 1,933 | 74 |
30 Jun 20 | 5,236 | 1,568 | 2,399 | 55 |
31 Mar 20 | 5,730 | 1,743 | 2,634 | 27 |
31 Dec 19 | 6,224 | 1,919 | 2,869 | 0 |
30 Sep 19 | 5,162 | 1,598 | 2,356 | 0 |
30 Jun 19 | 4,099 | 1,276 | 1,843 | 0 |
31 Mar 19 | 3,305 | 1,109 | 1,441 | 0 |
31 Dec 18 | 2,510 | 943 | 1,038 | 0 |
30 Sep 18 | 2,466 | 961 | 968 | 0 |
30 Jun 18 | 2,422 | 980 | 897 | 0 |
31 Mar 18 | 2,012 | 813 | 731 | 0 |
31 Dec 17 | 1,602 | 647 | 565 | 0 |
30 Sep 17 | 1,325 | 557 | 443 | 0 |
30 Jun 17 | 1,048 | 467 | 322 | 0 |
31 Mar 17 | 995 | 424 | 318 | 0 |
31 Dec 16 | 942 | 381 | 314 | 0 |
30 Sep 16 | 904 | 354 | 294 | 0 |
30 Jun 16 | 866 | 327 | 274 | 0 |
31 Mar 16 | 779 | 297 | 236 | 0 |
31 Dec 15 | 693 | 266 | 197 | 0 |
30 Sep 15 | 637 | 236 | 190 | 0 |
30 Jun 15 | 581 | 207 | 183 | 0 |
31 Mar 15 | 511 | 171 | 177 | 0 |
31 Dec 14 | 441 | 135 | 170 | 0 |
31 Dec 13 | 316 | 58 | 141 | 0 |
質の高い収益: 1558 非現金収入 のレベルが高いです。
利益率の向上: 1558の現在の純利益率 (29.7%)は、昨年(20.1%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 1558の収益は過去 5 年間で年間2.1%減少しました。
成長の加速: 1558の過去 1 年間の収益成長率 ( 44.7% ) は、5 年間の平均 ( 年間-2.1%を上回っています。
収益対業界: 1558の過去 1 年間の収益成長率 ( 44.7% ) はPharmaceuticals業界6.4%を上回りました。
株主資本利益率
高いROE: 1558の 自己資本利益率 ( 17.5% ) は 低い とみなされます。